Kurokawa, Yukinori
Yang, Han-Kwang
Cho, Haruhiko
Ryu, Min-Hee
Masuzawa, Toru
Park, Sook Ryun
Matsumoto, Sohei
Lee, Hyuk-Joon
Honda, Hiroshi
Kwon, Oh Kyoung
Ishikawa, Takashi
Lee, Kyung Hee
Nabeshima, Kazuhito
Kong, Seong-Ho
Shimokawa, Toshio
Yook, Jeong-Hwan
Doki, Yuichiro
Im, Seock-Ah
Hirota, Seiichi
Hahn, Seokyung
Nishida, Toshirou
Kang, Yoon-Koo
Article History
Received: 3 January 2017
Revised: 15 April 2017
Accepted: 26 April 2017
First Online: 23 May 2017
Competing interests
: Yukinori Kurokawa has received honoraria from Novartis, Pfizer, and Taiho. Haruhiko Cho has received honoraria from Novartis, Pfizer, and Bayer. Kazuhito Nabeshima has received honoraria from Pfizer. Seiichi Hirota has received honoraria from Novartis. Toshirou Nishida has received honoraria from Novartis, Pfizer, Bayer, and Taiho. Han-Kwang Yang, Min-Hee Ryu, Sook Ryun Park, Hyuk-Joon Lee, Oh Kyoung Kwon, Kyung Hee Lee, Seong-Ho Kong, Jeong-Hwan Yook, Yuichiro Doki, Seock-Ah Im, Seiichi Hirota, Seokyung Hahn, Toshirou Nishida, and Yoon-Koo Kang have received grant support from Novartis. All other authors declare no competing interests.